Vanguard FTSE Developed All Cap Ex North America Index ETF (TSX: VIU)
Assets | 5.04B |
Expense Ratio | 0.23% |
PE Ratio | 13.78 |
Dividend (ttm) | 0.88 |
Dividend Yield | 2.45% |
Ex-Dividend Date | Dec 30, 2024 |
Payout Frequency | Quarterly |
Payout Ratio | 37.22% |
1-Year Return | +12.37% |
Volume | 39,137 |
Open | 35.91 |
Previous Close | 36.05 |
Day's Range | 35.71 - 35.98 |
52-Week Low | 31.90 |
52-Week High | 35.98 |
Beta | 1.02 |
Holdings | 3735 |
Inception Date | Dec 1, 2015 |
About VIU
Vanguard FTSE Developed All Cap Ex North America Index ETF is an exchange traded fund launched and managed by Vanguard Investments Canada Inc. It is co-managed by Vanguard Global Advisers, LLC. The fund invests in public equity markets of global ex-US/Canada region. It invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the FTSE Developed All Cap ex North America Index, by using full replication technique. Vanguard FTSE Developed All Cap Ex North America Index ETF was formed on December 1, 2015 and is domiciled in Canada.
Performance
VIU had a total return of 15.25% in the past year. Since the fund's inception, the average annual return has been 6.71%, including dividends.
Top 10 Holdings
11.35% of assetsName | Symbol | Weight |
---|---|---|
ASML Holding N.V. | ASML | 1.39% |
SAP SE | SAP | 1.35% |
Novo Nordisk A/S | NOVO.B | 1.34% |
Toyota Motor Corporation | 7203 | 1.16% |
Msci Eafe Mar25 Ifus 20250321 | n/a | 1.13% |
Nestlé S.A. | NESN | 1.07% |
AstraZeneca PLC | AZN | 0.99% |
Novartis AG | NOVN | 0.98% |
Roche Holding AG | ROG | 0.98% |
Shell plc | SHEL | 0.96% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 30, 2024 | 0.19743 CAD | Jan 7, 2025 |
Sep 20, 2024 | 0.16085 CAD | Sep 27, 2024 |
Jun 21, 2024 | 0.44773 CAD | Jun 28, 2024 |
Mar 15, 2024 | 0.07459 CAD | Mar 25, 2024 |
Dec 28, 2023 | 0.19243 CAD | Jan 8, 2024 |
Sep 28, 2023 | 0.14742 CAD | Oct 10, 2023 |